IMPACT OF DIABETES ON LONG-TERM OUTCOMES IN STEMI PATIENTS UNDERGOING PRIMARY ANGIOPLASTY WITH GLYCOPROTEIN IIB-IIIA INHIBITORS AND BARE METAL STENTS (BMS) OR DRUG-ELUTING STENTS (DES)